NCLH vs VRDN · P/E 16, rev $4.97B vs rev $425.0K
Norwegian Cruise Line Holdings Ltd (NCLH) versus Viridian Therapeutics Inc (VRDN) — a side-by-side from cached financials, not a winner call.
Norwegian Cruise Line Holdings Ltd (NCLH) is a travel services company listed on NYSE.
Viridian Therapeutics Inc (VRDN) is a biotechnology company listed on US.
Latest reported NCLH revenue for 2026-06-30 was $4.97B. Net income was $327.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
Latest reported VRDN revenue for 2026-06-30 was $425.0K. Net income was -$232.0M. VRDN currently screens at market cap $1.39B.
NCLH currently screens at market cap $9.10B and trailing P/E 16.0. VRDN currently screens at market cap $1.39B.
Not investment advice. Open the NCLH and VRDN stock pages for the full models.
Not investment advice.